DNA tests have potential to transform next 70 years of NHS care, experts say

July 9, 2018 by Euan Wemyss, University of Aberdeen

Patients in Scotland could benefit from a revolution in personalised healthcare, thanks to major investments in gene sequencing technology.

Researchers say pioneering techniques that can sequence a person's entire genetic make-up in under three days have the potential to transform patient care in the coming decades.

The setting up of two cutting-edge centres for sequencing, in Edinburgh and Glasgow, and the contribution of NHS staff from across Scotland, have laid the foundations that will make the transformation possible.

Work carried out by the Scottish Genomes Partnership, a collaboration led by the Universities of Edinburgh, Glasgow, Aberdeen and Dundee and NHS Scotland, has given researchers unprecedented access to sequencing technologies.

Findings from the project are already helping to improve diagnoses of in the Scottish NHS, as well as advancing the understanding of rare and common diseases including cancer.

More than 400 NHS Scotland patients and their families have now had their entire genetic make-up decoded under the scheme. NHS Scotland Regional Genetics Services have identified sufficient patients with rare inherited conditions to allocate the remainder of the 1,000 genomes available in Scotland as part of the 100,000 Genomes Project.

Professor Tim Aitman, Director of the Centre of Genomic and Experimental Medicine at the University of Edinburgh, is Co-Chair of the Scottish Genomes Partnership.

He said: "As the NHS turns 70, it is the perfect opportunity for the Scottish Genomes Partnership to highlight its hope for the future through the successful between four of Scotland's medical schools, the NHS Scotland Genetics and Laboratory services and Genomics England.

"This technology offers one of the biggest opportunities in today's NHS, delivering precise molecular information that is changing the management of diseases. It could also ultimately enable prevention of diseases. We look forward to working with participants and funders to deliver the next phase of genomic medicine to the people of Scotland."

Professor Andrew Biankin, Director of the Wolfson Wohl Cancer Research Centre at the University of Glasgow and Co-Chair of the Scottish Genomes Partnership, said: "Genomic testing allows us to start predicting which therapies will work best for an individual cancer patient, improving outcomes whilst minimising side-effects and cost. The NHS is optimally positioned to lead in the development and implementation of precision medicine strategies for cancer."

The Scottish Genomes Partnership has received funding from NHS Scotland, the Scottish Government and the UK Medical Research Council. It is collaborating with Genomics England as part of the 100,000 Genomes Project.

Lead clinician for the NHS Scotland Genetics Consortium and lead clinical geneticist for the Scottish Genomes Partnership, Professor Zosia Miedzybrodzka of the University of Aberdeen, said: "NHS Scotland scientists and clinicians will be working over the next year to turn the complex DNA sequence data we have collected already into test results that can make a real difference to the lives of patients and their families."

Fiona Murphy, Director of the NHS National Services Division, said: "Innovation has driven huge changes in the NHS over the past 70 years with new technologies bringing benefits to all patients. Genomics will be central to future medical advances and it is fantastic to be part of the SGP leading a new wave of innovation in the NHS in Scotland."

Explore further: Gene study to shed light on how some people stay sharp in old age

Related Stories

Gene study to shed light on how some people stay sharp in old age

June 6, 2016
More than one thousand people have had their entire genetic make-up decoded as part of a long-term study to gain insight into why some people's brains age better than others.

Scotland launches world's first national atlas of palliative care

September 23, 2016
The first Scottish Atlas of Palliative Care has been by University of Glasgow academics at a major palliative care conference in Edinburgh.

'Unacceptable' cancer treatment waiting times condemned as Scottish targets missed again

March 30, 2017
Waiting times for cancer patients in Scotland have been described as 'unacceptable' after new figures show that a key target has been missed for the fourth year in a row.

Recommended for you

Why some human genes are more popular with researchers than others

September 18, 2018
Historical bias is a key reason why biomedical researchers continue to study the same 10 percent of all human genes while ignoring many genes known to play roles in disease, according to a study publishing September 18 in ...

Class of neurological disorders share 3-D genome folding pattern, study finds

September 18, 2018
In a class of roughly 30 neurological disorders that includes ALS, Huntington's Disease and Fragile X Syndrome, the relevant mutant gene features sections of repeating base pair sequences known as short tandem repeats, or ...

Researchers resolve decades-old mystery about the most commonly mutated gene in cancer

September 18, 2018
The most commonly mutated gene in cancer has tantalized scientists for decades about the message of its mutations. Although mutations can occur at more than 1,100 sites within the TP53 gene, they arise with greatest frequency ...

Study of one million people leads to world's biggest advance in blood pressure genetics

September 17, 2018
Over 500 new gene regions that influence people's blood pressure have been discovered in the largest global genetic study of blood pressure to date, led by Queen Mary University of London and Imperial College London.

Genetic mutations thwart scientific efforts to fully predict our future

September 17, 2018
Ever since the decoding of the human genome in 2003, genetic research has been focused heavily on understanding genes so that they could be read like tea leaves to predict an individual's future and, perhaps, help them stave ...

Gene therapy via skin protects mice from lethal cocaine doses

September 17, 2018
There are no approved medications to treat either cocaine addiction or overdose. Frequent users tend to become less and less sensitive to the drug, leading to stronger or more frequent doses. The typical result is addiction. ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.